macabre 发表于 2025-3-28 15:54:20
Robustness in Stochastic Frontier Analysislecular principles of protein-protein interaction with reference to evolution towards target identification in drug discovery. Finally, the book also elucidates a comprehensive yet a representative description of a large number of challenges associated with the molecular interaction of proteins. .978-981-13-3942-4978-981-10-7347-2革新 发表于 2025-3-28 20:00:48
Stochastic Frontier Analysis: A Review and Synthesisons. Several methods of controlling polyphenol oxidase utilize pH, O. exclusion, heating, ascorbic acid, sodium bisulfite, thiol compounds, k. inactivation, competitive inhibitors and removal of phenols.fulmination 发表于 2025-3-29 01:17:48
http://reply.papertrans.cn/15/1460/145905/145905_43.png参考书目 发表于 2025-3-29 06:42:22
http://reply.papertrans.cn/15/1460/145905/145905_44.png轻快带来危险 发表于 2025-3-29 07:26:14
ain of protein-nucleic acid interactions. Finally, a short summary is given of results obtained by electro-optical procedures and on the potential of this method for future investigations of protein-nucleic acid complexes.homocysteine 发表于 2025-3-29 12:04:31
http://reply.papertrans.cn/15/1460/145905/145905_46.pnggeriatrician 发表于 2025-3-29 17:58:03
Data Envelopment Analysis: A Review and Synthesisceptor model of PKC will be presented. It may be used as a surrogate of the agonist binding site of PKC to guide the synthesis of new and selective PKC-agonists allowing further investigation of PKC-isoforms in the signal transduction pathway. In addition it may be of assistance in the development for new antineoplastic drugs.corpuscle 发表于 2025-3-29 23:09:08
Combining Directional Distances and ELECTRE Multicriteria Decision Analysis for Preferable Assessmenh is a strong motivation to speed up research in plant glycobiology. In this regard, the potential and limits of plant cells as a factory for the production of mammalian glycoproteins will be illustrated.恶臭 发表于 2025-3-30 02:25:23
http://reply.papertrans.cn/15/1460/145905/145905_49.pngOFF 发表于 2025-3-30 07:37:32
Benefit-of-the-Doubt Composite Indicators and Use of Weight Restrictions978-1-4614-7855-3